Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High BACH2 gene Expression Is an Indicator of Poor Prognosis in Adult Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Rachel E Crossland, PhD, Tryfonia Mainou-Fowler, PhD, Michal Sieniawski, MD, Christopher Bacon, MBChB, PhD, Vikki Rand, PhD

Blood (2014) 124 (21): 3037.

https://doi.org/10.1182/blood.V124.21.3037.3037

Published: 2014

Journal Articles

Secondary Malignancies After Autologous Stem Cell Transplantation In Patients With Relapsed / Refractory Hodgkin´s Lymphoma. A Retrospective Analysis On Behalf Of The Lymphoma Working Party Of The European Society For Blood and Marrow Transplantation (EBMT)

Anna Sureda, MD, Ariane Boumendil, PhD, Michal Sieniawski, MD, Kirsty Thomson, MD, Martin Gramatzki, MD, Didier Blaise, Catherine Thieblemond, MD, Charles Crawley, MD, Marc Renaud, MD, Patrice Chevalier, MD, Jian Jian Luan, Kim H. Orchard, MD, Paneesha Shankara, MD, Urs Schanz, MD, Norbert Schmitz, Peter Dreger, MD

Blood (2013) 122 (21): 4636.

https://doi.org/10.1182/blood.V122.21.4636.4636

Published: 2013

Journal Articles

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Teresa V. Halbsguth, Lucia Nogová, Horst Mueller, Michal Sieniawski, Dennis A. Eichenauer, Thomas Schober, Hiltrud Nisters-Backes, Peter Borchmann, Volker Diehl, Andreas Engert, Andreas Josting

Blood (2010) 116 (12): 2026–2032.

https://doi.org/10.1182/blood-2009-11-253211

Published: 2010

Journal Articles

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

Michal Sieniawski, Nithia Angamuthu, Kathryn Boyd, Richard Chasty, John Davies, Peter Forsyth, Fergus Jack, Simon Lyons, Philip Mounter, Paul Revell, Stephen J. Proctor, Anne L. Lennard

Blood (2010) 115 (18): 3664–3670.

https://doi.org/10.1182/blood-2009-07-231324

Published: 2010

Journal Articles

Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens.

Michal Sieniawski, James Lennard, Christopher Millar, Simon Lyons, Philip Mounter, Zor Maung, Stephen J. Proctor, Anne L. Lennard

Blood (2009) 114 (22): 1660.

https://doi.org/10.1182/blood.V114.22.1660.1660

Published: 2009

Journal Articles

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Michal Sieniawski, MD, Malcolm Farrow, Xiao Zhao, Jennifer Wilkinson, Tryfonia Mainou-Fowler, Jo White, John MacIntyre, Stephen J. Proctor

Blood (2009) 114 (22): 1666.

https://doi.org/10.1182/blood.V114.22.1666.1666

Published: 2009

Journal Articles

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Michal Sieniawski, Jennifer Wilkinson, Dominic Culligan, John Davies, John Goodlad, Ruth Jarrett, Anne L Lennard, Helen Lucraft, Tryfonia Mainou-Fowler, Pam McKay, Fiona Scott, Sudhir Tauro, Jo White, Stephen J Proctor

Blood (2008) 112 (11): 2604.

https://doi.org/10.1182/blood.V112.11.2604.2604

Published: 2008

Journal Articles

Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches – Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group

Michal Sieniawski, MD, Nithia Angamuthu, Kathryn Boyd, Richard Chasty, John Davies, Paul Revell, Stephen J Proctor, Anne L Lennard

Blood (2008) 112 (11): 578.

https://doi.org/10.1182/blood.V112.11.578.578

Published: 2008

Journal Articles

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)

Michal Sieniawski, Thorsten Reineke, Lucia Nogova, Andreas Josting, Beate Pfistner, Volker Diehl, Andreas Engert

Blood (2008) 111 (1): 71–76.

https://doi.org/10.1182/blood-2007-02-073544

Published: 2008

Includes: Supplemental data

Journal Articles

Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.

Michal Sieniawski, MD, Andreas Josting, MD, Carmen Canals, MD, Anthony H. Goldstone, MD, Martin Gramatzki, MD, Didier Blaise, MD, Christian Gisselbrecht, MD, Charles Crawley, MD, Philippe Colombat, MD, Jean-Luc Harousseau, MD, Peter Johnson, MD, Angelo Michele Carella, MD, Anna Sureda, MD, Gerard Socie, MD, Norbert Schmitz, MD

Blood (2007) 110 (11): 834.

https://doi.org/10.1182/blood.V110.11.834.834

Published: 2007

Journal Articles

Fertility in Male Hodgkin Lymphoma Patients - A Report of German Hodgkin Study Group.

Michal Sieniawski, Dr, Thorsten Reineke, Dr, Andreas Josting, Dr, Volker Diehl, Prof, Andreas Engert, Prof

Blood (2006) 108 (11): 101.

https://doi.org/10.1182/blood.V108.11.101.101

Published: 2006

Journal Articles

Rituximab Added to an Intensified Salvage Chemotherapy Program Followed by Autologous Stem Cell Transplantation Improve in Relapsed and Refractory Aggressive Non-Hodgkin-Lymphoma.

Michal Sieniawski, MD, Jan-Peter Glossmann, MD, Thorsten Reineke, PhD, Volker Diehl, MD, Andreas Engert, MD, Andreas Josting, MD

Blood (2005) 106 (11): 1150.

https://doi.org/10.1182/blood.V106.11.1150.1150

Published: 2005

Journal Articles

A New BACOPP Schedule Is Feasible and Effective in Elderly Hodgkin’s Lymphoma Patients - Interim Results of a Multicenter Phase-II Trial of the German Hodgkin Study Group (GHSG).

Lucia Nogova, MD, Michal Sieniawski, MD, Hildrud Nisters-Backes, Veronika Jennissen, MD, Volker Diehl, MD, Andreas Engert, MD, Andreas Josting, MD

Blood (2005) 106 (11): 4735.

https://doi.org/10.1182/blood.V106.11.4735.4735

Published: 2005

Journal Articles

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Andreas Josting, MD, Jeremy Franklin, PhD, Michal Sieniawski, MD, Beate Pfistner, PhD, Thomas Schober, Hildtrud Nisters-Backes, Andreas Engert, MD, Volker Diehl, MD

Blood (2005) 106 (11): 818.

https://doi.org/10.1182/blood.V106.11.818.818

Published: 2005

Journal Articles

Fertility in Male Patients with Hodgkin’s Disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).

Michal Sieniawski, Andreas Josting, Kai Breuer, Volker Diehl, Andreas Engert

Blood (2004) 104 (11): 1315.

https://doi.org/10.1182/blood.V104.11.1315.1315

Published: 2004

Journal Articles

Comparison of the Sequential High-Dose Chemotherapy Followed by Autologous Stem Cell Support with and without Rituximab in Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma.

Michal Sieniawski, Jan Oliver Staak, Helena Scheuss, Jan Peter Glossmann, Volker Diehl, Andreas Engert, Andreas Josting

Blood (2004) 104 (11): 919.

https://doi.org/10.1182/blood.V104.11.919.919

Published: 2004

NARROW

High BACH2 gene Expression Is an Indicator of Poor Prognosis in Adult Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Secondary Malignancies After Autologous Stem Cell Transplantation In Patients With Relapsed / Refractory Hodgkin´s Lymphoma. A Retrospective Analysis On Behalf Of The Lymphoma Working Party Of The European Society For Blood and Marrow Transplantation (EBMT)

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens.

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)

Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.

Fertility in Male Hodgkin Lymphoma Patients - A Report of German Hodgkin Study Group.

Rituximab Added to an Intensified Salvage Chemotherapy Program Followed by Autologous Stem Cell Transplantation Improve in Relapsed and Refractory Aggressive Non-Hodgkin-Lymphoma.

A New BACOPP Schedule Is Feasible and Effective in Elderly Hodgkin’s Lymphoma Patients - Interim Results of a Multicenter Phase-II Trial of the German Hodgkin Study Group (GHSG).

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Fertility in Male Patients with Hodgkin’s Disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).

Comparison of the Sequential High-Dose Chemotherapy Followed by Autologous Stem Cell Support with and without Rituximab in Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only